FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213025295> ?p ?o ?g. }

• W4213025295 endingPage "604" @default.
• W4213025295 startingPage "594" @default.
• W4213025295 abstract "Processed aconite root (PA), the tuberous root of Aconitum carmichaelii prepared by autoclaving, is a crude drug used in Japanese traditional Kampo medicine and traditional Chinese medicine for the symptoms of kidney deficiency, that is related to the muscle atrophy in modern medicine. The objective of the present study is to evaluate the effectiveness of PA on muscle atrophy and to find its active ingredients using dexamethasone-induced muscle ring finger protein-1 (MuRF1) mRNA expression in murine myoblast C2C12 cells. Dexamethasone-induced MuRF1 expression was significantly suppressed by methanol-soluble part of boiling water extract of PA in a concentration-dependent manner with its IC50 value of 1.5 mg/ml. By the activity-guided fractionations of PA extract using the partition between organic solvents and its aqueous solution, the activity of PA did not transfer into the fraction containing aconitine-type diterpenoid alkaloids but into BuOH layer. Then, we found higenamine and salsolinol as the active ingredients in PA. Higenamine and salsolinol significantly suppressed dexamethasone-induced MuRF1 expression, and their IC50 values were 0.49 and 50 µM, respectively. The contents of higenamine and salsolinol in the decoctions of commercially available fourteen PA products are 0.12 and 14 µg/ml as the average values, and varied with the coefficient of variation (CV) values of 97 and 63%, respectively. Higenamine also significantly suppressed dexamethasone-induced mRNA expressions of muscle atrophy F-box protein (MAFbx)/atrogin1, casitas B-lineage lymphoma-b (Cbl-b), troponin, branched-chain amino acid aminotransferase 2 (BCAT2), and Bcl-2 binding and pro-apoptotic protein3 (Bnip3). Although the quality control of PA is regulated by the contents of diterpene alkaloids, salsolinol and higenamine can be used as the marker compounds to certificate the pharmacological activities of PA." @default.
• W4213025295 created "2022-02-24" @default.
• W4213025295 creator A5000606694 @default.
• W4213025295 creator A5018428621 @default.
• W4213025295 creator A5028029518 @default.
• W4213025295 creator A5035998238 @default.
• W4213025295 creator A5042223140 @default.
• W4213025295 creator A5065964457 @default.
• W4213025295 creator A5067678220 @default.
• W4213025295 creator A5069013042 @default.
• W4213025295 creator A5072448709 @default.
• W4213025295 creator A5083402775 @default.
• W4213025295 creator A5086258053 @default.
• W4213025295 creator A5090805856 @default.
• W4213025295 date "2022-02-18" @default.
• W4213025295 modified "2023-10-14" @default.
• W4213025295 title "Suppressive effects of processed aconite root on dexamethasone-induced muscle ring finger protein-1 expression and its active ingredients" @default.
• W4213025295 cites W1967568088 @default.
• W4213025295 cites W2016712537 @default.
• W4213025295 cites W2024736651 @default.
• W4213025295 cites W2032068252 @default.
• W4213025295 cites W2034912790 @default.
• W4213025295 cites W2047366370 @default.
• W4213025295 cites W2047663493 @default.
• W4213025295 cites W2054779453 @default.
• W4213025295 cites W2062333514 @default.
• W4213025295 cites W2094579915 @default.
• W4213025295 cites W2094933143 @default.
• W4213025295 cites W2132273917 @default.
• W4213025295 cites W2167033587 @default.
• W4213025295 cites W2219898540 @default.
• W4213025295 cites W2243792484 @default.
• W4213025295 cites W2281522791 @default.
• W4213025295 cites W2326550414 @default.
• W4213025295 cites W2407785316 @default.
• W4213025295 cites W2433708706 @default.
• W4213025295 cites W2488794713 @default.
• W4213025295 cites W2522538366 @default.
• W4213025295 cites W2583444100 @default.
• W4213025295 cites W2598351622 @default.
• W4213025295 cites W2761889806 @default.
• W4213025295 cites W2898714172 @default.
• W4213025295 cites W2937419897 @default.
• W4213025295 cites W2946875693 @default.
• W4213025295 cites W3021347561 @default.
• W4213025295 cites W3023635004 @default.
• W4213025295 cites W3027060616 @default.
• W4213025295 cites W3115363154 @default.
• W4213025295 cites W3200002328 @default.
• W4213025295 cites W3213356049 @default.
• W4213025295 doi "https://doi.org/10.1007/s11418-022-01606-5" @default.
• W4213025295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35178660" @default.
• W4213025295 hasPublicationYear "2022" @default.
• W4213025295 type Work @default.
• W4213025295 citedByCount "1" @default.
• W4213025295 countsByYear W42130252952023 @default.
• W4213025295 crossrefType "journal-article" @default.
• W4213025295 hasAuthorship W4213025295A5000606694 @default.
• W4213025295 hasAuthorship W4213025295A5018428621 @default.
• W4213025295 hasAuthorship W4213025295A5028029518 @default.
• W4213025295 hasAuthorship W4213025295A5035998238 @default.
• W4213025295 hasAuthorship W4213025295A5042223140 @default.
• W4213025295 hasAuthorship W4213025295A5065964457 @default.
• W4213025295 hasAuthorship W4213025295A5067678220 @default.
• W4213025295 hasAuthorship W4213025295A5069013042 @default.
• W4213025295 hasAuthorship W4213025295A5072448709 @default.
• W4213025295 hasAuthorship W4213025295A5083402775 @default.
• W4213025295 hasAuthorship W4213025295A5086258053 @default.
• W4213025295 hasAuthorship W4213025295A5090805856 @default.
• W4213025295 hasBestOaLocation W42130252951 @default.
• W4213025295 hasConcept C134018914 @default.
• W4213025295 hasConcept C185592680 @default.
• W4213025295 hasConcept C190409667 @default.
• W4213025295 hasConcept C2776263037 @default.
• W4213025295 hasConcept C2778956427 @default.
• W4213025295 hasConcept C2779959927 @default.
• W4213025295 hasConcept C2780032014 @default.
• W4213025295 hasConcept C2780401358 @default.
• W4213025295 hasConcept C43617362 @default.
• W4213025295 hasConcept C55493867 @default.
• W4213025295 hasConcept C556039675 @default.
• W4213025295 hasConcept C71924100 @default.
• W4213025295 hasConcept C98274493 @default.
• W4213025295 hasConceptScore W4213025295C134018914 @default.
• W4213025295 hasConceptScore W4213025295C185592680 @default.
• W4213025295 hasConceptScore W4213025295C190409667 @default.
• W4213025295 hasConceptScore W4213025295C2776263037 @default.
• W4213025295 hasConceptScore W4213025295C2778956427 @default.
• W4213025295 hasConceptScore W4213025295C2779959927 @default.
• W4213025295 hasConceptScore W4213025295C2780032014 @default.
• W4213025295 hasConceptScore W4213025295C2780401358 @default.
• W4213025295 hasConceptScore W4213025295C43617362 @default.
• W4213025295 hasConceptScore W4213025295C55493867 @default.
• W4213025295 hasConceptScore W4213025295C556039675 @default.
• W4213025295 hasConceptScore W4213025295C71924100 @default.
• W4213025295 hasConceptScore W4213025295C98274493 @default.
• W4213025295 hasFunder F4320334764 @default.
• W4213025295 hasIssue "3" @default.

• next